Synthesis and Antimicrobial Activity Evaluation of Imidazole‐Fused Imidazothiadiazole Analogues

Three series of new imidazole‐fused imidazo[2,1‐b][1,3,4]thiadiazole analogues (compounds 20 a–g, 21 a–g, and 22 a–g) have been synthesized, and their antibacterial and antifungal activities have been evaluated. All the target compounds showed strong antifungal activity and high selectivity for the...

Full description

Saved in:
Bibliographic Details
Published in:ChemMedChem 2021-08, Vol.16 (15), p.2354-2365
Main Authors: Fang Yan Guo, Chang Ji Zheng, Wang, Meiyuan, Ai, Jiangping, Han, Lan Ying, Liu, Yang, Ye Fang Lu, Yang, Yu Xuan, Ming Guan Piao, Hu‐Ri Piao, Chun‐Mei Jin, Cheng, Hua Jin
Format: Article
Language:English
Subjects:
Aniline
Antifungal activity
Antifungal agents
Antimicrobial activity
Antimicrobial agents
Cytotoxicity
Fluconazole
Fungicides
Gatifloxacin
Gram-negative bacteria
Imidazole
Organic compounds
Selectivity
Thiadiazoles
Toxicity
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Three series of new imidazole‐fused imidazo[2,1‐b][1,3,4]thiadiazole analogues (compounds 20 a–g, 21 a–g, and 22 a–g) have been synthesized, and their antibacterial and antifungal activities have been evaluated. All the target compounds showed strong antifungal activity and high selectivity for the test fungus Candida albicans over Gram‐positive and ‐negative bacteria. N‐((4‐(2‐Cyclopropyl‐6‐(4‐fluorophenyl)imidazo[2,1‐b][1,3,4]thiadiazol‐5‐yl)‐5‐(6‐methyl‐pyridin‐2‐yl)‐1H‐imidazol‐2‐yl)methyl)aniline (21 a) showed the highest activity against C. albicans (MIC50=0.16 μg/mL), 13 and three times that of the positive control compounds gatifloxacin and fluconazole, respectively. Compounds 21 a and 20 e did not show cytotoxicity against human foreskin fibroblast‐1 cells, and compound 21 a was as safe as the positive control compounds in hemolysis tests. These results strongly suggest that some of the compounds produced in this work have value for development as antifungal agents.
ISSN:1860-7179
1860-7187
DOI:10.1002/cmdc.202100122